Evidence map›Paper›PMID 30151032›Full record

ArticleChinese medicine2018

Effects of different principles of Traditional Chinese Medicine treatment on TLR7/NF-κB signaling pathway in influenza virus infected mice.

Ying-Jie Fu, Yu-Qi Yan, Hong-Qiong Qin, Sha Wu, Shan-Shan Shi, Xiao Zheng, Peng-Cheng Wang, Xiao-Yin Chen, Xiao-Long Tang, Zhen-You Jiang

Open access · goldAbstract read
In one paragraph

Article in Chinese medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. [Comparison of anti-inflammatory, antibacterial and analgesic activities of formulated granulesNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2022
    Article
  19. Development and Effects of Influenza Antiviral Drugs.Molecules (Basel, Switzerland) · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ying-Jie Fu *1Department of Microbiology and Immunology, School of Basic Medical Sciences, Jinan University, Guangzhou, 510632 Guangdong China.ORCID 0000-0002-0476-8506
Yu-Qi Yan *1Department of Microbiology and Immunology, School of Basic Medical Sciences, Jinan University, Guangzhou, 510632 Guangdong China.
Hong-Qiong Qin1Department of Microbiology and Immunology, School of Basic Medical Sciences, Jinan University, Guangzhou, 510632 Guangdong China.
Sha Wu1Department of Microbiology and Immunology, School of Basic Medical Sciences, Jinan University, Guangzhou, 510632 Guangdong China.
Shan-Shan Shi1Department of Microbiology and Immunology, School of Basic Medical Sciences, Jinan University, Guangzhou, 510632 Guangdong China.
Xiao Zheng1Department of Microbiology and Immunology, School of Basic Medical Sciences, Jinan University, Guangzhou, 510632 Guangdong China.
Peng-Cheng Wang1Department of Microbiology and Immunology, School of Basic Medical Sciences, Jinan University, Guangzhou, 510632 Guangdong China.
Xiao-Yin Chen2College of Traditional Chinese Medicine, Jinan University, Guangzhou, 510632 Guangdong China.
Xiao-Long Tang3Medical College, Anhui University of Science & Technology, Huainan, 232001 Anhui China.
Zhen-You Jiang1Department of Microbiology and Immunology, School of Basic Medical Sciences, Jinan University, Guangzhou, 510632 Guangdong China.
Jinan University · CNAnhui University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfluenza virus is a single-stranded RNA virus that causes influenza in humans and animals. About 600 million people around the world suffer from influenza every year. Upon recognizing viral RNA molecules, TLR7 (Toll-like receptor) initiates corresponding immune responses. Traditional Chinese Medicines (TCMs), including Yinqiao powder, Xinjiaxiangruyin and Guizhi-and-Mahuang decoction, have been extensively applied in clinical treatment of influenza. Although the therapeutic efficacy of TCMs against influenza virus in vivo was reported previously, its underlying mechanisms are not clearly understood. This study aimed to investigate the immunological mechanisms in the treatment of influenza virus infected mice with three Chinese herbal compounds as well as the effect on TLR7/NF-κB signaling pathway during recovery.

methodsWild type and TLR7 KO C57BL/6 mice were infected with influenza virus FM1 and then treated with three TCMs. The physical parameters of mice (body weight and lung index) and the expression levels of components in TLR7/NF-κB signaling pathway were evaluated.

resultsAfter viral infection, Guizhi-and-Mahuang decoction and Yinqiao powder showed better anti-viral effect under normal condition. Compared to the viral control group, expression levels of TLR7, MyD88, IRAK4 and NF-κB were significantly reduced in all treatment groups. Furthermore, the three TCM treatment groups showed poor therapeutic efficacy and no difference in viral load compared to the viral control group in TLR7 KO mice.

conclusionOur study indicated that Guizhi-and-Mahuang decoction and Yinqiao powder might play a crucial role of anti-influenza virus by regulating TLR7/NF-κB signal pathway.

Indexed as

Guizhi-and-Mahuang decoctionInfluenza virusTLR7 gene knockoutTLR7/NF-κB signaling pathwayTraditional Chinese MedicineXinjiaxiangruyinYinqiao powder

Identifiers

PMID30151032
PMCPMC6102858
OpenAlexW2888531494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.